Nevirapine + multivitamins

Nevirapine + multivitamins is a combination involving the antiretroviral drug nevirapine and multivitamin supplements. Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection, while multivitamins are supplements containing various essential vitamins used to support overall health in patients with HIV. ## Description Nevirapine is an NNRTI that works by directly binding to HIV-1 reverse transcriptase and blocking the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzyme's catalytic site. It is used in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients. Multivitamins are supplements containing various essential vitamins that may be used to support overall health in patients with HIV. The specific interaction between nevirapine and multivitamins appears in drug interaction checkers, suggesting potential interactions that should be monitored. ## Administration and Dosage Nevirapine requires a 14-day lead-in period with 200 mg once daily dosing, followed by 200 mg twice daily maintenance dosing for the immediate-release formulation. For extended-release formulations, after the lead-in period with immediate-release tablets, patients transition to 400 mg once daily. The 14-day lead-in period must be strictly followed as it has been demonstrated to reduce the frequency of rash, a common side effect. ## Important Safety Information Nevirapine carries serious risks including: - Severe, life-threatening hepatotoxicity, particularly in patients with higher CD4+ cell counts (>250 cells/mm³ for females, >400 cells/mm³ for males) - Severe skin reactions, including Stevens-Johnson syndrome - Drug interactions with numerous medications due to its effect on cytochrome P450 enzymes ## Drug Interactions Nevirapine is known to interact with 446 drugs, including 78 major interactions, 350 moderate interactions, and 18 minor interactions. The search results specifically mention interactions with multivitamins, including Vitamin B Complex 100, Vitamin B1, B2, B6, B12, Vitamin C, Vitamin D3, and Vitamin K. Nevirapine is principally metabolized by the liver via cytochrome P450 isoenzymes 3A and 2B6 and is an inducer of these enzymes. This can lead to lower than expected plasma levels of other drugs metabolized by these enzyme systems when co-administered with nevirapine. ## Special Populations Dosage adjustments are required for patients with renal impairment on dialysis, who should receive an additional 200 mg dose following each dialysis treatment. Patients with hepatic fibrosis or cirrhosis should be monitored carefully, and nevirapine should not be administered to patients with Child-Pugh B or C liver disease.